NO20026280L - Melanokortin reseptor-ligander - Google Patents

Melanokortin reseptor-ligander

Info

Publication number
NO20026280L
NO20026280L NO20026280A NO20026280A NO20026280L NO 20026280 L NO20026280 L NO 20026280L NO 20026280 A NO20026280 A NO 20026280A NO 20026280 A NO20026280 A NO 20026280A NO 20026280 L NO20026280 L NO 20026280L
Authority
NO
Norway
Prior art keywords
receptor ligand
melanocortin receptor
melanocortin
ligand
receptor
Prior art date
Application number
NO20026280A
Other languages
English (en)
Other versions
NO20026280D0 (no
Inventor
Philip Albert Carpino
Bridget Mccarthy Cole
Bradley Paul Morgan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20026280L publication Critical patent/NO20026280L/no
Publication of NO20026280D0 publication Critical patent/NO20026280D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20026280A 2000-06-28 2002-12-30 Melanokortin reseptor-ligander NO20026280D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21461600P 2000-06-28 2000-06-28
PCT/IB2001/000995 WO2002000654A1 (en) 2000-06-28 2001-05-31 Melanocortin receptor ligands

Publications (2)

Publication Number Publication Date
NO20026280L true NO20026280L (no) 2002-12-30
NO20026280D0 NO20026280D0 (no) 2002-12-30

Family

ID=22799775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026280A NO20026280D0 (no) 2000-06-28 2002-12-30 Melanokortin reseptor-ligander

Country Status (26)

Country Link
US (1) US20020072604A1 (no)
EP (1) EP1294719A1 (no)
JP (1) JP2004501917A (no)
KR (1) KR20030017571A (no)
CN (1) CN1440406A (no)
AP (1) AP2001002196A0 (no)
AR (1) AR030301A1 (no)
AU (1) AU2001260548A1 (no)
BG (1) BG107268A (no)
BR (1) BR0111567A (no)
CA (1) CA2412563A1 (no)
EA (1) EA200201119A1 (no)
EC (1) ECSP024404A (no)
IL (1) IL152781A0 (no)
IS (1) IS6617A (no)
MA (1) MA26920A1 (no)
MX (1) MXPA03000063A (no)
NO (1) NO20026280D0 (no)
OA (1) OA12296A (no)
PA (1) PA8521501A1 (no)
PE (1) PE20020208A1 (no)
PL (1) PL360855A1 (no)
TN (1) TNSN01097A1 (no)
UY (1) UY26804A1 (no)
WO (1) WO2002000654A1 (no)
ZA (1) ZA200210277B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001264977B2 (en) * 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
JP2004532838A (ja) 2001-03-02 2004-10-28 ブリストル−マイヤーズ スクイブ カンパニー メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物
US6911447B2 (en) 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7354923B2 (en) * 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) * 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
CA2462200A1 (en) * 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
JP2005519876A (ja) 2001-11-27 2005-07-07 メルク　エンド　カムパニー　インコーポレーテッド ２−アミノキノリン化合物
US7026335B2 (en) 2002-04-30 2006-04-11 The Procter & Gamble Co. Melanocortin receptor ligands
TW200504033A (en) 2002-10-23 2005-02-01 Procter & Gamble Melanocortin receptor ligands
CA2515717A1 (en) 2003-02-10 2004-08-19 Banyu Pharmaceutical Co., Ltd. Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
JP2005306839A (ja) * 2003-08-29 2005-11-04 Takeda Chem Ind Ltd 二環性ピペラジン化合物およびその用途
US7795267B2 (en) 2003-08-29 2010-09-14 Takeda Pharmaceutical Company Limited Bicyclic piperazine compound having TGR23 antagonistic activity
BRPI0508787A (pt) * 2004-04-08 2007-09-04 Astellas Pharma Inc composto ws727713, cepa de actinomiceto, composto com atividade moduladora de receptor de melanocortina, processo para produzir o composto ws727713, modulador de receptor de melanocortina, uso do composto e composição farmacêutica
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
DK3354273T3 (da) * 2005-07-08 2021-06-28 Ipsen Pharma Melanocortinreceptorligander
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
WO2008007664A1 (fr) 2006-07-11 2008-01-17 Takeda Pharmaceutical Company Limited Composé hétérocyclique bicycique et son utilisation
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
KR20090042967A (ko) 2006-08-14 2009-05-04 베링거 인겔하임 인터내셔날 게엠베하 플리반세린 제형 및 이의 제조방법
EA200900270A1 (ru) 2006-08-25 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Системы регулируемого высвобождения и способ их приготовления
JP5250026B2 (ja) 2007-05-25 2013-07-31 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ ヒダントインで修飾したメラノコルチン受容体リガンド
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
JP5562865B2 (ja) 2007-12-17 2014-07-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｔｒｐｖ１のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055679A1 (en) * 1998-04-28 1999-11-04 Trega Biosciences, Inc. Isoquinoline compound melanocortin receptor ligands and methods of using same
CA2334551A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
AU766191B2 (en) * 1999-06-04 2003-10-09 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists

Also Published As

Publication number Publication date
CA2412563A1 (en) 2002-01-03
EP1294719A1 (en) 2003-03-26
MXPA03000063A (es) 2003-09-25
US20020072604A1 (en) 2002-06-13
TNSN01097A1 (fr) 2005-11-10
BR0111567A (pt) 2003-05-06
PE20020208A1 (es) 2002-03-13
PA8521501A1 (es) 2002-10-24
UY26804A1 (es) 2002-01-31
KR20030017571A (ko) 2003-03-03
JP2004501917A (ja) 2004-01-22
IL152781A0 (en) 2003-06-24
ECSP024404A (es) 2003-02-06
OA12296A (en) 2006-05-12
AR030301A1 (es) 2003-08-20
ZA200210277B (en) 2003-12-19
NO20026280D0 (no) 2002-12-30
MA26920A1 (fr) 2004-12-20
BG107268A (en) 2003-06-30
IS6617A (is) 2002-11-14
CN1440406A (zh) 2003-09-03
WO2002000654A1 (en) 2002-01-03
PL360855A1 (en) 2004-09-20
EA200201119A1 (ru) 2003-06-26
AU2001260548A1 (en) 2002-01-08
AP2001002196A0 (en) 2002-12-21

Similar Documents

Publication Publication Date Title
NO20026280L (no) Melanokortin reseptor-ligander
NO20014568D0 (no) Melanokortin reseptor-ligander
AU9631301A (en) Melanocortin receptor ligands
DE50113985D1 (de) Halterung
DE60125312D1 (de) Mikroarray
IL157969A0 (en) Melanocortin receptor ligands
DE60135144D1 (de) Verbinder
DE60143422D1 (de) Verbinder
DE50106084D1 (de) Kopfstütze
DE10196653T1 (de) Kopfstütze
DE60026949D1 (de) Verbinder
EE200200680A (et) Parendatud luminofoorid
NO20023895D0 (no) Anilin-avledete ligander for thyroid-reseptoren
DE60102506D1 (de) Verbinder
DE60109409D1 (de) Neigungsverstellmechanismus
NO20025502L (no) Kombinasjons kjemoterapi
DE60110137D1 (de) Biochip
DE60119875D1 (de) Verbinder
IT1315483B1 (it) Benna vagliatrice - miscelatrice
DE60109670D1 (de) Verbinder
DE60106146D1 (de) Verbinder
DE60112673D1 (de) Verbinder
DE60107134D1 (de) Verbinder
DE60100973D1 (de) Verbinder
DE60107105D1 (de) Sicherheitsgurtanordnung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application